Interview: Nkaki Matlala – Vice-Chairman of the Public Health Enhancement…
The Vice-Chairman of the Public Health Enhancement Fund talks about how the shortage of medical doctors and the fight against TB, HIV and AIDS in South Africa led the health…
Working together to enhance health. No single sector in South Africa, whether public or private, can successfully confront the immense challenge of the quadruple burden of disease. It requires combined forces, shared vision and commitment to working together. The Minister of Health officially launched the Social Compact Forum on 8 November 2012. The launch of the Forum was applauded by government and the ANC, as an initiative that leads the way for cooperation between the public and private sectors.
Establishing a social compact in healthcare. To achieve this noble vision the Minister and participating private sector companies established a Social Compact Forum and the Public Health Enhancement Fund (PHEF). The Social Compact Forum which will interact with the Minister and the Public Health Enhancement Fund (PHEF) is a financing instrument established by the Social Compact.
The Public Health Enhancement Fund (PHEF) will be managed by the private sector through the establishment of a not for profit entity in accordance with the Companies Act. Collection and disbursement of funds will be for the benefit of transformative healthcare projects, to be jointly agreed to between the Minister and the private sector. Payments from the fund will be made directly to vendors or, in the case of projects, to the providers of services to the beneficiaries of the projects, as determined by the Board of the PHEF from time to time. The rationale for the fund is for private sectors to contribute in strengthening the health sector and to build trust between the public and private sector. The initiative also aims to leverage the funds within the private sector to maximise benefits for the types of projects envisaged, rather than adopting an individual or silo approach which results in a number of fragmented, smaller projects which do not necessarily have the impact that is required. Ultimately, it is envisaged that this institutionalised engagement will assist in shaping a better future healthcare system for all, regardless of whether they be from the private or public health sector. The funding formula has been developed by corporate lawyers, auditors and BBBEE consultants to ensure that the contributions into the fund are recognised under the Socio-Economic Development (SED) element of the BBBEE balanced scorecard. Empowerdex has confirmed this. The BBBEE Act and its balanced scorecard require companies to spend 1% of Net Profit after tax (NPAT) for maximal SED recognition. The funding formula for the PHEF requires 0,75% for participation in the Fund. This means that participants would contribute 75% of their required SED obligation into the fund. Participation in the initiative comes at no additional cost or earnings dilution, unless companies decide to exceed the 1% NPAT scorecard requirement. Contributing companies stand to benefit from an institutionalised engagement with government, through less fragmentation of SED activities and more efficient channelling of resources.
Contact:
Tel: 011 239 6734
Fax: 011 239 6018
Address:
Building 8, Healthcare Park,
Woodlands Drive, Woodmead, 2191
Web: www.phef.co.za
The Vice-Chairman of the Public Health Enhancement Fund talks about how the shortage of medical doctors and the fight against TB, HIV and AIDS in South Africa led the health…
David Mukanga of the Bill and Melinda Gates Foundation gives an overview of the latest developments on the long road towards the creation of an African Medicines Agency and the…
Kelly Chibale, founder of the H3D Centre at the University of Cape Town and chairman & CEO of the H3D Foundation, outlines the rationale behind the establishment of these institutions,…
Medicines for Africa’s Lenias Hwenda highlights the vast gaps in COVID-19 vaccine access globally, especially in Africa where just six percent of the population has been vaccinated. Hwenda argues that…
Three months after the World Bank announced a EUR 600 million loan to South Africa’s Aspen Pharmacare, the African continent has received more good news as it seeks to increase…
In a notable first, following successful pilot immunisation programmes in Ghana, Kenya and Malawi, the World Health Organization (WHO) has recommended that the RTS,S malaria vaccine be rolled out across…
A roundup of the latest news from South African pharma, including Aspen’s impressive annual growth, Adcock Ingram’s full year profit drop, and Entos Pharma’s approval for Phase II clinical rials…
With Africa struggling to vaccinate its populations against COVID-19, the World Bank – along with government institutions from the USA, Germany, and France – has intervened to loan South African…
The latest from South African pharma, including President Ramaphosa’s blunt criticism of Big Pharma, Aspen’s reception of USD 700 million in international financial aid, Adcock Ingram’s disappointing results as fewer…
South African firm Aspen has inked a deal with Johnson & Johnson for the technical transfer and proposed commercial manufacture of their COVID-19 vaccine candidate, Ad26.COV2-S, boosting the company’s share…
As COVID-19 threatens to derail more than a decade’s worth of hard-won gains in the fight against malaria, Dr Benjamin Pretorius, managing director at ERADA Technology Alliance, warns that diversions…
The South African affiliate of Indian pharma firm Cipla will begin manufacturing and distribution of remdesivir, a Covid-19 drug, in South Africa this month. The company’s priority is ensuring access…
Below is a roundup of latest news from South Africa’s life sciences and healthcare industries, including a call to overhaul patent laws to allow better access to COVID-19 drugs, innovation…
See our Cookie Privacy Policy Here